Campbell & CO Investment Adviser LLC Dynavax Technologies Corp Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$13.09 - $14.98 $518,455 - $593,312	39,607 New	39,607 $553,000
Q2 2022 Aug 09, 2022	SELL	$7.45 - $12.83 $135,590 - $233,506	-18,200 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$9.75 - $14.44 $177,450 - $262,808	18,200 New	18,200 $197,000
Q3 2021 Nov 10, 2021	SELL	$9.16 - $19.83 $110,836 - $239,942	-12,100 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$7.25 - $10.99 $87,725 - $132,979	12,100 New	12,100 $119,000
Q4 2020 Feb 09, 2021	SELL	$3.73 - $5.6 $127,939 - $192,080	-34,300 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$4.32 - $11.7 $148,176 - $401,310	34,300 New	34,300 $148,000

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.57B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.